Elanco Animal Health (ELAN) Non Operating Interest Expenses (2018 - 2024)

Elanco Animal Health has disclosed Non Operating Interest Expenses across 7 years of filings, most recently posting $58.0 million for Q3 2024.

• In Q3 2024, Non Operating Interest Expenses fell 19.44% year-over-year to $58.0 million; the TTM figure through Sep 2024 stood at $256.0 million (down 5.88% YoY), while the FY2023 annual figure was $277.0 million, up 14.94% from the prior year.
• Non Operating Interest Expenses came in at $58.0 million for Q3 2024 at Elanco Animal Health, down from $65.0 million in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $74.0 million in Q2 2023 to a low of $16.0 million in Q1 2020.
• Average Non Operating Interest Expenses over 5 years is $57.5 million, with a median of $60.4 million recorded in 2020.
• Year-over-year, Non Operating Interest Expenses retreated 23.08% in 2020 and surged 281.25% in 2021.
• Over 5 years, Non Operating Interest Expenses stood at $60.4 million in 2020, then decreased by 8.94% to $55.0 million in 2021, then increased by 12.73% to $62.0 million in 2022, then increased by 8.06% to $67.0 million in 2023, then dropped by 13.43% to $58.0 million in 2024.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $58.0 million in Q3 2024, $65.0 million in Q2 2024, and $66.0 million in Q1 2024.